3E Bioventures Capital β Full Portfolio
44 tracked investments Β· listed companies and verified rows first
C4 Therapeutics develops small molecule medicines called degraders that use targeted protein degradation (TPD) to eliminate disease-causing proteins via the body's ubiquitin proteasome system.
BiotechCambridge, US
Marc Cohen(Executive Officer, Director)Jason Fisherman(Executive Officer, Director)Miles Stuchin(Director)William M. Scalzulli(Director)Kenneth Anderson(Director)Malcolm S. Salter(Director)
Nasdaq: CGTX.
Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets.
BiotechDeep TechHardwareHealthtechMedical DevicesBellevue, US
Wenbin Jiang, Ph.D.(CEO and Chairman of the Board)Ming Yan, Ph.D.(Chief Technology Officer)Ming Yan(Executive Officer, Director)Jiecheng Zhang(Director)Allen Poirson(Director)Andrew Levin(Director)
Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Francisco, US
Bill Fawcett(Co-founder)Ben Healy(CEO)Natalie Wisniewski(Executive Officer, Director)Qianye Karen Liu(Director)Ben Hwang(Executive Officer, Director)Thomas Gutshall(Director)
Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals.
BiotechDeep TechSemiconductorsSouth San Francisco, US
Emily Marine Leproust(Executive Officer, Director, Promoter)William Charles Banyai(Executive Officer, Director, Promoter)Bill James Peck(Executive Officer, Promoter)Rob Chess(Director)
BoardKeith Crandell(Director)Paul Conley(Director)
Dermaliq Therapeutics is a specialty pharmaceutical company developing topical dermatology therapies and medical skin care products based on its proprietary hyliQ drug-delivery platform, with a lead pipeline focused on hair loss conditions such as androgenetic alopecia and alopecia areata.
BiotechHealthtechWilmington, US
Oliver SchlΓΌter(CFO & Co-Founder)Betsy Hughes-Formella(CSO & Co-Founder / R&D Consultant)Christian Roesky(CEO & President)
ProNovo Therapeutics is a biotechnology company developing precision small-molecule therapeutics for neuropsychiatric disorders, including Major Depressive Disorder and Schizophrenia.
BiotechHealthtechMental Health
Guang Chen(Founder, Board Director & Chief Scientific Officer)Xiaohu Deng(Co-Founder & CEO)Scott Thompson(Co-Founder & Chair of Scientific Advisory Board)
Mediaspace is a digital agency that designs and builds custom Squarespace websites and provides SEO, digital marketing strategy, and digital advertising services.
AdTechAdvanced ManufacturingAI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHardwareHealthtechMarketing TechMedical DevicesSemiconductorsAtlanta, US
Ronald P. Thiboutot(Director)William D. McPhee(Director)John G. Edwards(Executive Officer, Director)John Jacobi(Executive Officer)Sri Peruvemba(Executive Officer)Francois Jeanneau(Executive Officer, Director)
BiotechHouston, US
Rudy Howard(Chief Financial Officer)Fredric N. Eshelman(Executive Chairman of the Board of Directors)Sigurd C. Kirk(Director)Michael W. Rogers(Director)Peter T.C. Ho(Director)Robert B. Geller(Chief Medical Officer)
Reimagining RNA medicines to silence disease drivers or restore missing function.
Avirmax is a preclinical-stage biopharmaceutical company developing AAV-based genetic medicines to treat chronic and degenerative ocular diseases.
BiotechDeep TechMedical DevicesHayward, US
Yu Fang(Director of the Issuer)Qianye Karen Liu(Director of the Issuer)Haifeng Chen(Director and Treasurer of the Issuer)Shengjiang Liu(Executive Officer, Director)Nancy Chang(Director of the Issuer)
Cullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITEβ’ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach.
BiotechDeep TechHealthtechMedical Devices
Ying Luo(CEO)
Nasdaq: CTKB.
Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.
AI & Machine LearningBiotechDeep TechBoston, US
Mark Murcko, Ph.D.(Director)Richard Young, Ph.D.(Director)Elisabeth Leiderman(Executive Officer)Ameet Nathwani, M.D.(Executive Officer, Director)Isaac Klein, M.D., Ph.D.(Executive Officer)Lori Escobedo(Executive Officer)
Eaglenos develops smart healthcare technologies, focusing on precision testing and personalized health management.
Digital HealthHealthtechMedical DevicesNanjing, CN
Innovative ocular therapeutics for China and global markets.
The company develops flagship products for medical and industrial markets, focusing on building differentiated, IP-protected features and trade secrets.
Deep TechHardwareMedical Devices
Galaxy Brain Scientific is a neuroscience technology company developing a platform for individualized brain functional mapping and non-invasive precision neuromodulation.
BiotechDeep TechMedical Devices
Digital ELISA protein-detection platform with ultra-high sensitivity, throughput and dynamic range.
Genotix develops single-molecule detection technology to digitally characterize and quantitate biomarkers, aiming to reveal early indicators of disease.
BiotechHealthtechMedical Devices
Targeting intersections for precision immunotherapy, especially in antigen presentation.
Advancing a molecule to treat diseases associated with excess body fat including NASH, Prader-Willi syndrome, and antipsychotic drug-induced weight gain.
Lipidio Pharma is developing a drug that targets the skin's endocrine signaling mechanisms to produce systemic effects such as weight and total body fat reduction.
BiotechSan Diego, US
David Bullough(Director)Daniel Petree(Director)J. Gordon Foulkes(Executive Officer, Director)
HealthtechPoulsbo, US
Tracy Puckett(Executive Officer)Clark Tedford(Executive Officer, Director)Scott Bradley(Executive Officer)Duane Morrison(Executive Officer)Cindy Croissant(Executive Officer)Ryan Montecucco(Executive Officer)
Focused on lysosomal ion channel disease biology.
Developing small-molecule therapeutics targeting common disease mechanisms to restore brain health.
Super-resolution microscopic imaging platform originating from a Nobel Prize winner's laboratory.
Company from Harvard Medical School and MIT McGovern Institute aiming to solve brain disorders.
OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders.
BiotechHealthtechRockville, US
Martin Devenport(Executive Officer)Yang Liu(Co-founder)Michael Flaschen(Director)Pan Zheng(Co-founder)
First-in-class biologic drug targeting the CD24-Siglec innate immunity signaling pathway.
BiotechRockville, US
Pan Zheng(Executive Officer)Kun-Liang Guan(Director)Miao Hong(Director)Martin Devenport(Executive Officer)Yang Liu(Executive Officer, Director)Gary Fanger(Director)
Advancing precision therapeutics for neuropsychiatric disorders.
Quadriga Biosciences is developing QBS72S, a chemotherapeutic drug candidate that uses the L-type Amino Acid Transporter 1 (LAT1) to cross the blood brain barrier and enter cancer cells, where it forms DNA interstrand cross-links to kill the cells.
BiotechHealthtech
Developing a cure for ADPKD patients.
Biotechnology research organization (est. 2016) focused on uric acid metabolism, inflammatory pain, and gout metabolic syndrome.
Shanton Pharma is a clinical-stage biotech company developing drugs for gout, hyperuricemia, and pruritus.
BiotechHealthtech
Smartlens develops ophthalmic technologies for anterior segment disease management, including miLens, a non-invasive wearable microfluidic contact lens for remote intraocular pressure monitoring, an AI-powered remote examination platform for anterior segment conditions, and an automated micro-dose medication delivery device.
AI & Machine LearningDigital HealthMedical Devices
Subtle Medical develops deep learning software for medical imaging that enables faster and safer image acquisition on existing scanners for healthcare providers and imaging centers.
AI & Machine LearningHealthtechMedical Devices
Greg Zaharchuk(Co-founder, MD, Ph.D., Neuroradiologist and Professor at Stanford)inEnhao Gong(Co-founder, Ph.D., Deep Learning Scientist)in
Nasdaq: TWST.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.